Bionano (BNGO) Q3 2025 Earnings Call Transcript

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...
Le Lézard

European Commission Approves BRINSUPRItm (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced ...

Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...
Le Lézard

Pivot Bio Expands Weatherproof Nitrogen Portfolio with New Dry Planter Box Treatments for Corn and Cotton

Pivot Bio, one of the world's leading innovative agtech companies, today announced the launch of new dry planter box treatments for its nitrogen-fixing technology, Pivot Bio PROVEN® G3 Dry for corn ...